variables: 821643

This table contains all the variables of all the datasets we have at Our World In Data. Note that this includes only the information about the variables like name and default display settings, not the data itself.

Data license: CC-BY

This data as json

id name unit description createdAt updatedAt code coverage timespan datasetId sourceId shortUnit display columnOrder originalMetadata grapherConfigAdmin shortName catalogPath dimensions schemaVersion processingLevel processingLog titlePublic titleVariant attributionShort attribution descriptionShort descriptionFromProducer descriptionKey descriptionProcessing licenses license grapherConfigETL type sort dataChecksum metadataChecksum
821643 Access restrictions to maintenance treatment - Maintenance access restrictions: Age restriction     2024-03-06 13:51:02 2024-07-25 23:12:59     2014-2014 6403     
{}
 0     access_restrictions_to_maintenance_treatment__maintenance_access_restrictions_age_restriction grapher/who/2024-01-03/gho/access_restrictions_to_maintenance_treatment#access_restrictions_to_maintenance_treatment__maintenance_access_restrictions_age_restriction 
{
    "filters": [
        {
            "name": "maintenance_access_restrictions",
            "value": "Age restriction"
        }
    ],
    "originalName": "Access restrictions to maintenance treatment",
    "originalShortName": "access_restrictions_to_maintenance_treatment"
}
 2             Access restrictions to pharmacotherapies for maintenance treatment of opioid dependence, such as age restriction, restriction on the duration of opioid dependence prior to treatment or restrictions for injecting drug users. This only applies to countries where any agonist pharmacotherapies is available for maintenance treatment. ##### Definition Access restrictions to pharmacotherapies for maintenance treatment of opioid dependence, such as age restriction, restriction on the duration of opioid dependence prior to treatment or restrictions for injecting drug users. This only applies to countries where any agonist pharmacotherapies is available for maintenance treatment. ##### Method of estimation The national authorities of a given country respond to the WHO ATLAS survey on resources for the prevention and treatment of substance use disorders. 
[]
         string 
[]
 e74b7505b48938dda96496344fc40de9 90ec38c7c63f8598a27f2bb41f246cdd

Links from other tables